Diagnostic agent and therapeutic agent for pancreatic cancer
US8211630B2 · kind B2 · utility
0Cited by
0References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 18, 2007 |
| Grant date | Jul 3, 2012 |
| Priority date | — |
| Expiry date | Mar 15, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a novel diagnostic or therapeutic method for pancreatic cancer employing a blood marker. The present invention provides a diagnostic or therapeutic drug for pancreatic cancer containing an anti-AMIGO2 antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.